Stock Price Quote

ASTER DM QUALITY CARE LTD.

NSE : ASTERDMBSE : 540975ISIN CODE : INE914M01019Industry : Hospital & Healthcare ServicesHouse : Private
BSE865.90-3.05 (-0.35 %)
PREV CLOSE ( ) 868.95
OPEN PRICE ( ) 868.05
BID PRICE (QTY) 866.05 (136)
OFFER PRICE (QTY) 867.15 (188)
VOLUME 13810
TODAY'S LOW / HIGH ( )863.40 882.85
52 WK LOW / HIGH ( )519.8 890.95
NSE865.25-1.9 (-0.22 %)
PREV CLOSE( ) 867.15
OPEN PRICE ( ) 867.15
BID PRICE (QTY) 865.25 (77)
OFFER PRICE (QTY) 865.50 (39)
VOLUME 162414
TODAY'S LOW / HIGH( ) 864.00 883.20
52 WK LOW / HIGH ( )519.1 891.3
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 18-01 2008
Management Info
Azad Moopen - Chairman Varun Khanna - Managing Director
Registered Office

Address Awfis, 2nd Floor, Renaissance Centra,27 & 27/1, Mission Road,Sampangi Rama Nagar,
Bengaluru,
Karnataka-560027

Phone 0484 6699999

Email info@asterdmhealthcare.com / cs@asterdmhealthcare.in

Website www.asterdmhealthcare.in

Registrars Details
MUFG Intime India Pvt Ltd.
Surya, 35 Mayflower Avenue,Behind Senthil Nagar,Sowripalayam Road,Coimbatore
Listing : BSE, NSE

NEWS

15Jul Aster DM Healthcare informs about disc
Aster DM Healthcare has informed that it enclosed disclosure under Regul..
14Jul Aster DM Healthcare informs about disc
Aster DM Healthcare has informed that the Exchange has received the disc..
06Jul Aster DM Healthcare informs about disc
Aster DM Healthcare has informed that the exchange has received the disc..
04Jul Aster DM Quality Care informs about c
Aster DM Quality Care has informed that pursuant to Clause 21 (i) of the..
01Jul Appointment of Director
Employees Stock Option Plan Inter alia, approved :- A. CHANGE IN BOAR..

Financials

in Millions
QTR Jun 26 ANNUAL 26
Net Profit-142.9999999999992678.2
Gross Profit 108.900000000001 3742
Operating Profit 1860.27054.1
Net Sales 7257.326157

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Narayana Hrudayalay. (BSE)
peergroup  1846.95 (0.67%)
M.Cap ( in Cr)37494.08
Vijaya Diagnostic (BSE)
peergroup  1401.90 (0.66%)
M.Cap ( in Cr)14345.01
Nephrocare Health (BSE)
peergroup  705.20 (1.30%)
M.Cap ( in Cr)7000.42
Suraksha Diagnostic (BSE)
peergroup  272.35 (2.52%)
M.Cap ( in Cr)1383.53
Healthcare Global (BSE)
peergroup  722.00 (0.92%)
M.Cap ( in Cr)10681.08

Shareholding Pattern

PROMOTERS 40.39%
MUTUAL FUNDS/UTI 26.7%
NON-INSTITUTION 21.42%
FI/BANKS/INSURANCE 0.55%
GOVERNMENT 0%
FII 0%

About Aster DM Quality Care Ltd.

Aster DM Quality Care Ltd. was incorporated in the year 2008. Its today's share price is 865.9. Its current market capitalisation stands at Rs 75743.98 Cr. In the latest quarter, company has reported Gross Sales of Rs. 23204.8 Cr and Total Income of Rs.80591.5 Cr. The company's management includes V K Mathews, Ayshwarya Vikram, Kewal Handa, Neeraj Jain, Varun Khanna, Mandayapurath Azad Moopen, Hemish Purushottam, James Mathew , Thadathil Joseph Wilson, Sunil Theckath Vasudevan, Purana Housdurgamvijaya Deepti, Alisha Moopen, Azad Moopen, Azad Moopen.

It is listed on the BSE with a BSE Code of 540975 , NSE with an NSE Symbol of ASTERDM and ISIN of INE914M01019. It's Registered office is at Awfis, 2nd Floor, Renaissance Centra,27 & 27/1, Mission Road,Sampangi Rama NagarBengaluru-560027, Karnataka. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Associates, BSR & Associates LLP, Deloitte Haskins & Sells, Singhi & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.